Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hope Grows for Autism is a non-profit organization dedicated to advancing medical cannabis solutions for symptoms related to Autism Spectrum Disorder (ASD). Founded in 2016 by Erica Daniels, the organization focuses on advocacy, education, and research to improve the lives of individuals with autism and their families. Hope Grows for Autism was instrumental in the development of the HOPE™ product line, which includes pharmaceutical-grade cannabis tinctures formulated specifically for autism symptoms. Through partnerships with entities like Zelira Therapeutics and the Children's Hospital of Philadelphia, the organization facilitates clinical research and works to reduce the stigma surrounding cannabinoid-based treatments. The organization also provides resources and community support to help families navigate the legal and medical complexities of cannabis therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hope Grows for Autism.